开发和验证患者报告的评估骨髓瘤治疗类固醇影响的结果测量:多发性骨髓瘤类固醇症状问卷。

IF 2.3 4区 医学 Q1 NURSING
Tracy King, Louise Acret, Claudia Rutherford, Margaret-Ann Tait, Jacqueline Jagger, Julija Sipavicius, Georgia McCaughan, Douglas Joshua, Kate White
{"title":"开发和验证患者报告的评估骨髓瘤治疗类固醇影响的结果测量:多发性骨髓瘤类固醇症状问卷。","authors":"Tracy King, Louise Acret, Claudia Rutherford, Margaret-Ann Tait, Jacqueline Jagger, Julija Sipavicius, Georgia McCaughan, Douglas Joshua, Kate White","doi":"10.1016/j.soncn.2025.151943","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Steroids routinely used in the treatment of multiple myeloma (MM) are associated with adverse effects affecting health-related quality of life (HRQoL). No assessment tool existed to measure the impact of steroids in this population. We developed and psychometrically evaluated the Steroid Symptom Questionnaire-Multiple Myeloma (SSQ-MM).</p><p><strong>Methods: </strong>A conceptual framework for steroid-related PROs was developed through a systematic review and qualitative interviews. An existing tool was adapted and pretested with patients (n = 5), carers (n = 3), and clinicians (n = 9) for relevance and face validity. In field test 1, the draft-SSQ-MM was administered to 70 patients. Items were chosen based on item-level analysis for acceptability. In Field Test 2, the psychometric properties of the final SSQ-MM were assessed in 140 patients as part of a multicenter study. The SSQ-MM was administered alongside the EORTC QLQ-C30 and MY20, with the SSQ-MM administered again 1 week later.</p><p><strong>Results: </strong>The SSQ-MM contains 20 items. Stability reliability was supported (ICC = 0.846), and item-total correlations ranged between 0.266 and 0.677, excluding hiccups and blood glucose, which were retained due to clinical relevance. Exploratory factor analysis supported a total score and four multi-item subscales with acceptable internal consistency (α = 0.64 to 0.82). We found evidence of convergent and divergent validity between scales measuring similar and dissimilar constructs on QLQ-C30. The SSQ-MM total score was able to differentiate between patient groups clinically known to differ.</p><p><strong>Conclusions: </strong>The SSQ-MM provides a validated PROM for use in research and clinical settings to assess the impact of steroids and identify those who may benefit from dose reduction to improve PROs, including HRQoL.</p><p><strong>Implications for nursing practice: </strong>Integrating assessment of steroid adverse effects using the SSQ-MM into routine nursing care can help direct timely interventions or referrals to assist patients better manage the emotional and behavioural effects of steroids. Dose optimisation may reduce steroid effects and improve HRQoL.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151943"},"PeriodicalIF":2.3000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development and Validation of a Patient-Reported Outcome Measure to Assess the Impact of Steroids in the Treatment of Myeloma: The Steroid Symptom Questionnaire-Multiple Myeloma.\",\"authors\":\"Tracy King, Louise Acret, Claudia Rutherford, Margaret-Ann Tait, Jacqueline Jagger, Julija Sipavicius, Georgia McCaughan, Douglas Joshua, Kate White\",\"doi\":\"10.1016/j.soncn.2025.151943\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Steroids routinely used in the treatment of multiple myeloma (MM) are associated with adverse effects affecting health-related quality of life (HRQoL). No assessment tool existed to measure the impact of steroids in this population. We developed and psychometrically evaluated the Steroid Symptom Questionnaire-Multiple Myeloma (SSQ-MM).</p><p><strong>Methods: </strong>A conceptual framework for steroid-related PROs was developed through a systematic review and qualitative interviews. An existing tool was adapted and pretested with patients (n = 5), carers (n = 3), and clinicians (n = 9) for relevance and face validity. In field test 1, the draft-SSQ-MM was administered to 70 patients. Items were chosen based on item-level analysis for acceptability. In Field Test 2, the psychometric properties of the final SSQ-MM were assessed in 140 patients as part of a multicenter study. The SSQ-MM was administered alongside the EORTC QLQ-C30 and MY20, with the SSQ-MM administered again 1 week later.</p><p><strong>Results: </strong>The SSQ-MM contains 20 items. Stability reliability was supported (ICC = 0.846), and item-total correlations ranged between 0.266 and 0.677, excluding hiccups and blood glucose, which were retained due to clinical relevance. Exploratory factor analysis supported a total score and four multi-item subscales with acceptable internal consistency (α = 0.64 to 0.82). We found evidence of convergent and divergent validity between scales measuring similar and dissimilar constructs on QLQ-C30. The SSQ-MM total score was able to differentiate between patient groups clinically known to differ.</p><p><strong>Conclusions: </strong>The SSQ-MM provides a validated PROM for use in research and clinical settings to assess the impact of steroids and identify those who may benefit from dose reduction to improve PROs, including HRQoL.</p><p><strong>Implications for nursing practice: </strong>Integrating assessment of steroid adverse effects using the SSQ-MM into routine nursing care can help direct timely interventions or referrals to assist patients better manage the emotional and behavioural effects of steroids. Dose optimisation may reduce steroid effects and improve HRQoL.</p>\",\"PeriodicalId\":54253,\"journal\":{\"name\":\"Seminars in Oncology Nursing\",\"volume\":\" \",\"pages\":\"151943\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminars in Oncology Nursing\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.soncn.2025.151943\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NURSING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Oncology Nursing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.soncn.2025.151943","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0

摘要

目的:用于治疗多发性骨髓瘤(MM)的常规类固醇与影响健康相关生活质量(HRQoL)的不良反应相关。没有评估工具来衡量类固醇对这一人群的影响。我们开发了类固醇症状问卷-多发性骨髓瘤(SSQ-MM)并进行了心理测量学评估。方法:通过系统回顾和定性访谈,建立类固醇相关PROs的概念框架。对现有工具进行调整,并对患者(n = 5)、护理人员(n = 3)和临床医生(n = 9)进行相关性和面部效度预测试。在现场试验1中,70例患者服用了draft-SSQ-MM。项目的选择是基于项目层面的可接受性分析。在现场测试2中,作为一项多中心研究的一部分,对140名患者进行了最终SSQ-MM的心理测量特性评估。SSQ-MM与EORTC QLQ-C30和MY20一起使用,SSQ-MM在1周后再次使用。结果:SSQ-MM量表共20个项目。稳定性可靠度得到支持(ICC = 0.846),项目-总相关性在0.266 ~ 0.677之间,不包括打嗝和血糖,由于临床相关性而保留。探索性因子分析支持总分和四个多条目子量表具有可接受的内部一致性(α = 0.64 ~ 0.82)。我们发现在QLQ-C30上测量相似和不同构式的量表之间存在趋同效度和发散效度的证据。SSQ-MM总分能够区分临床已知存在差异的患者组。结论:SSQ-MM提供了一个经过验证的PROM,可用于研究和临床环境,以评估类固醇的影响,并确定那些可能受益于减少剂量以改善PROs的患者,包括HRQoL。对护理实践的影响:使用SSQ-MM将类固醇不良反应评估整合到常规护理中,可以帮助直接及时干预或转诊,以帮助患者更好地管理类固醇的情绪和行为影响。剂量优化可减少类固醇效应,改善HRQoL。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Development and Validation of a Patient-Reported Outcome Measure to Assess the Impact of Steroids in the Treatment of Myeloma: The Steroid Symptom Questionnaire-Multiple Myeloma.

Objectives: Steroids routinely used in the treatment of multiple myeloma (MM) are associated with adverse effects affecting health-related quality of life (HRQoL). No assessment tool existed to measure the impact of steroids in this population. We developed and psychometrically evaluated the Steroid Symptom Questionnaire-Multiple Myeloma (SSQ-MM).

Methods: A conceptual framework for steroid-related PROs was developed through a systematic review and qualitative interviews. An existing tool was adapted and pretested with patients (n = 5), carers (n = 3), and clinicians (n = 9) for relevance and face validity. In field test 1, the draft-SSQ-MM was administered to 70 patients. Items were chosen based on item-level analysis for acceptability. In Field Test 2, the psychometric properties of the final SSQ-MM were assessed in 140 patients as part of a multicenter study. The SSQ-MM was administered alongside the EORTC QLQ-C30 and MY20, with the SSQ-MM administered again 1 week later.

Results: The SSQ-MM contains 20 items. Stability reliability was supported (ICC = 0.846), and item-total correlations ranged between 0.266 and 0.677, excluding hiccups and blood glucose, which were retained due to clinical relevance. Exploratory factor analysis supported a total score and four multi-item subscales with acceptable internal consistency (α = 0.64 to 0.82). We found evidence of convergent and divergent validity between scales measuring similar and dissimilar constructs on QLQ-C30. The SSQ-MM total score was able to differentiate between patient groups clinically known to differ.

Conclusions: The SSQ-MM provides a validated PROM for use in research and clinical settings to assess the impact of steroids and identify those who may benefit from dose reduction to improve PROs, including HRQoL.

Implications for nursing practice: Integrating assessment of steroid adverse effects using the SSQ-MM into routine nursing care can help direct timely interventions or referrals to assist patients better manage the emotional and behavioural effects of steroids. Dose optimisation may reduce steroid effects and improve HRQoL.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Seminars in Oncology Nursing
Seminars in Oncology Nursing Nursing-Oncology (nursing)
CiteScore
3.40
自引率
0.00%
发文量
68
审稿时长
45 days
期刊介绍: Seminars in Oncology Nursing is a unique international journal published six times a year. Each issue offers a multi-faceted overview of a single cancer topic from a selection of expert review articles and disseminates oncology nursing research relevant to patient care, nursing education, management, and policy development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信